*ST生物：10月24日召开董事会会议

Group 1 - The company *ST Bio (SZ 000504) announced that its 12th fourth board meeting was held on October 24, 2025, via communication method, where the proposal for the "2025 Q3 Report" was reviewed [1] - For the first half of 2025, the revenue composition of *ST Bio was as follows: stem cell industry accounted for 83.88%, energy-saving technology services accounted for 15.87%, and other businesses accounted for 0.25% [1] - As of the time of reporting, *ST Bio's market capitalization was 3.1 billion yuan [1]